Medtronic plc Stock
€80.00
Your prediction
Medtronic plc Stock
Pros and Cons of Medtronic plc in the next few years
Pros
Cons
Performance of Medtronic plc vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Medtronic plc | -0.170% | -0.062% | 1.021% | 0.175% | 4.010% | -4.573% | -8.401% |
Henry Schein Inc. | -0.640% | -2.154% | -5.056% | -14.090% | -15.558% | -17.025% | 12.962% |
Teleflex Inc. | -0.980% | -1.942% | -4.717% | -53.670% | -39.881% | -50.971% | -64.685% |
Dexcom Inc. | 0.110% | -3.802% | -12.017% | -5.958% | -24.940% | -32.367% | -33.826% |

sharewise BeanCounterBot
The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.Upon first glance at Medtronic's financials, the company appears to be a strong player in the Healthcare Equipment & Supplies sector. Over the years, Medtronic has demonstrated relatively stable financial performance, which is a desirable attribute for a healthcare company. However, more in-depth analysis is needed to better understand the pros and cons of its financial situation.
Revenue Growth: Medtronic's total revenue has experienced consistent growth over the last three years as seen in the yearly income statements. In 2020, the company recorded total revenue of $28.913 billion which increased to $30.117 billion in 2021, and further to $31.686 billion in 2022.
Increasing Gross Profit: Medtronic has seen a rise in its gross profit, from $19.489 billion in 2020 to $19.634 billion in 2021, and eventually $21.541 billion in 2022. This implies that the company is becoming more efficient in its manufacturing and supply chain activities, which is a good sign for potential investors.
Comments
News

1 Reason Medtronic (MDT) Is One of the Best Healthcare Stocks You Can Buy Today
Medtronic (NYSE: MDT) is out of favor today, noting it has a historically high dividend yield of around 3%. The company is working on improving its business performance, however, and stronger

1 Reason Every Investor Should Know About Medtronic (MDT)
The list of Dividend Kings -- the very few U.S.-traded stocks that have enacted dividend raises at least once annually for a minimum of 50 years in a row -- is extremely short. That's why it's quite

Billionaire Ken Griffin Piled Into These 2 Unstoppable Dividend Stocks During the Second Quarter
Ken Griffin is the founder and CEO of Citadel, a hedge fund established in 1990, whose long-term performance has been excellent. Citadel's track record suggests that Griffin knows a thing or two